Althea Group Holdings

Althea Group Holdings Althea Group Holdings Ltd (ASX:AGH) is a global leader in the manufacturing, sales and distribution of cannabis-based medicines and consumer packaged goods.

Althea Group Holdings Ltd (‘AGH’) is a global leader in the manufacturing, sales and distribution of cannabis-based medicines and recreational cannabis products. AGH provides high-quality pharmaceutical and recreational cannabis products, delivered by two distinct business verticals: Althea who supply to the global cannabis-based medicines market and Peak Processing Solutions, who supply to the legal cannabis market in Canada. Founded in Australia, AGH now have operations across 4 continents in highly regulated and legal cannabis markets, operating in Europe, North America, Australia and Africa.

Would you like to hear more from the ASX company driving innovation across the world's largest regulated cannabis market...
16/09/2022

Would you like to hear more from the ASX company driving innovation across the world's largest regulated cannabis markets?

Althea Group Holdings (ASX: AGH) CEO & Managing Director Joshua Fegan will be providing the latest updates from the company and recaps the year to date of news flow and results. Click here to register: https://lnkd.in/gDGVkvtc

Althea Group Holdings (ASX: AGH) is a revenue generating high growth business. AGH strategic commercial initiatives have...
15/09/2022

Althea Group Holdings (ASX: AGH) is a revenue generating high growth business. AGH strategic commercial initiatives have the business well placed for further growth FY2023 and beyond.
AGH offers investors unique access to international medical cannabis and recreational cannabis markets.

Click here to read more:https://wcsecure.weblink.com.au/pdf/AGH/02567799.pdf

Althea Group Holdings (ASX: AGH) CEO & Managing Director Joshua Fegan, highlights the year-on-year revenue growth, which...
09/09/2022

Althea Group Holdings (ASX: AGH) CEO & Managing Director Joshua Fegan, highlights the year-on-year revenue growth, which is going from strength to strength on both sides of the business, medical cannabis, and recreational cannabis.

Althea Group Holdings is focused on achieving profitability, and operating profit for financial year 2023. Click to read the Annual Financial Report https://lnkd.in/g2a6twcn

Cannabis-based medicine supplier, Althea Group (ASX:AGH) has recorded growth across most key metrics in its two arms of business for the 2022 financial year.

14/07/2022

Althea Group Holdings (ASX:AGH) Chief Financial Officer Rob Meissner Chief Financial Officer announced the group’s record end to the 2022 financial year, with a total of $22 million in cash receipts, a hundred percent increase year on year.

10/03/2022

Ensure you stay up to date with all the news from Althea Group Holdings. The new AGH website includes an all new and improved investor centre, providing investors with all the latest information from the group. Visit https://altheagroupholdings.com/investor-centre

Althea Group Holdings has rapidly become a leader in both the medicinal and recreational cannabis markets. Visit the new...
07/03/2022

Althea Group Holdings has rapidly become a leader in both the medicinal and recreational cannabis markets. Visit the new website to learn more about Althea and Peak Processing Solutions. Click https://lnkd.in/gDyKNfM8

02/03/2022

Have you seen the new AGH website? It’s time to check us out!
Althea Group Holdings recently launched a new and improved website, providing investors with greater insights and information about our great organisation. Visit: altheagroupholdings.com

28/02/2022

Althea Group Holdings Ltd’s (ASX:AGH) Chief Financial Officer Rob Meissner highlights the group’s half year performance underpinned by strong fundamentals within the Althea pharmaceutical (Althea) and Peak Processing Solutions recreational (Peak) businesses. AGH achieved revenues of just under AU$9.4M and cash receipts of AU$9.9m. Althea’s revenue for the period was just under $6M, finishing the year with approximately 1,300 doctors prescribing Althea medicines to just under 30,000 patients. The commercialisation and success of Peak in the last 6 months has resulted in $3.6M in revenue and $4.3M in cash receipts. Click here to find out more https://jwp.io/s/DESq8G0b

23/02/2022

We are excited to announce the official launch of the new Althea Group Holdings branding. After many months of strategic development and design, the branding will be brought to life with a new and improved website. Our CEO & Managing Director provides an exclusive insight into the new brand and website.
Click the following link to read the full media release.https://altheagroupholdings.com/wp-content/uploads/2022/02/AGH-brand-launch-Media-Announcement_23.2.22.pdf

20/01/2022

Althea Group Holdings (ASX:AGH) Managing Director & CEO Joshua Fegan and Rob Meissner Chief Financial Officer announced the group’s record quarter, with $5.5M in receipts from customers, and $9.9M for the first half of the financial year.

This growth was driven by the easing of COVID 19 restrictions impacting Althea’s pharmaceutical business and, separately, the commercialisation of recreational products from Peak Processing Solutions which is forecasting to achieve $15M in receipts from customers in financial year 2022. The Group is expecting another big quarter for Q1 2022.

16/12/2021

Peak Continues to Strengthen its Presence in the Canadian Legal Cannabis Market

Joshua Fegan, CEO and Managing Director, Althea Group Holdings (AGH) is looking well ahead into the future and believes that recreational cannabis is going to develop into a global market over the next 5-10 years in countries such as the USA, Mexico, Germany, Switzerland, and others. Find out more: https://lnkd.in/gG7r3eN6

Address

360 Elizabeth Street
Melbourne, VIC
3000

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Alerts

Be the first to know and let us send you an email when Althea Group Holdings posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Althea Group Holdings:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Althea Company Pty Ltd aims to improve the quality of life of Australians suffering from debilitating conditions by providing education and patient access to high quality medicinal cannabis products.

Althea Company was founded in Melbourne in 2017 with a view to acquiring the necessary licences and permits to import, cultivate, produce and supply medicinal cannabis for eligible patients across Australia. In May 2018, Althea commenced sales of five Althea branded medicinal cannabis products to eligible patients across Australia.

Althea’s team of medical science liaisons across the country help educate health care professionals about medicinal cannabis and provide clarity and support to navigate the complexities of regulation and patient access.